ArticleFrontiers in endocrinology2025
Continuous auricular acupuncture and daytime intermittent electroacupuncture as a complementary therapeutic improve glycemic variability and stability under Continuous Glycemic Monitoring System in hospitalized diabetic patients.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the effects of continuous (24h) Auricular acupuncture (AAC) alone and combined with intermittent (20-30 mins daytime, three times per week) Electroacupuncture (EAC) on blood glucose variability (GV) and stability via (Con) CGMS. This approach goes beyond mean glucose levels and could serve as a key determinant of metabolic instability and complication risk in diabetes. The study focused on hospitalized patients with Diabetes Mellitus (DM) and explored their distinct roles across different diurnal segments. Methods: This retrospective study, conducted at the Department of Endocrinology from 2023 to 2025, analyzed Continuous Glucose Monitoring System (CGMS) data from categorized patient groups (CGMS control, AAC, and AAC+EAC, n=984). Statistical analyses focused on overall mean blood glucose (MBG) and segment-specific (24h, 0-4h, 4-8h, 8-20h, 20-24h) ambulatory glucose profile (AGP) percentiles. Results: No significant difference in 24-hour MBG was observed among groups (P = 0.9297). Both AAC and AAC+EAC significantly reduced higher glucose percentiles (P75, P90, P95) across 24 hours and during daytime (8-20h) compared to controls. AAC alone was shown to have lower MBG in mid-to-high glucose ranges (P25-P95) during non-EAC periods (0-4h, 4-8h, 20-24h). Both AAC and AAC+EAC groups consistently exhibited significantly higher MBG at lower percentiles (P5, P10) than controls during all segments (0-4h, 4-8h, 20-24h). Notably, during daytime (8-20h), AAC+EAC showed significantly higher P5, P10, and P25 values compared to controls and AAC alone. Conclusion: Continuous AAC and daytime intermittent EAC effectively reduce glycemic variability in hospitalized patients. AAC provides sustained, broad-spectrum control over glycemic fluctuations in higher percentiles. Daytime EAC uniquely helps prevent lower glucose excursions during its use, indicating a protective role against daytime hypoglycemia. These findings support personalized, complementary interventions for optimized diabetes management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.